SEC Form 4 · accession 0000882104-16-000249
PDL BIOPHARMA, INC. · PDLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Lewis Stone
Officer — VP, Gen. Counsel & Secretary
Period of report
Dec 13, 2016
Accepted (ET)
Dec 15, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 13, 2016 | D | 1,935 | $0.00 | D | 234,374 | D |
Table II — derivative securities
No Table II lines on this filing.